Home » today » Business » BioNTech targets a turnover of 17 billion euros for vaccines in 2022

BioNTech targets a turnover of 17 billion euros for vaccines in 2022

In the presentation slides for JP Morgan’s annual healthcare conference, which is being held virtually this year, BioNTech said it expected the vaccine to bring it between $ 13 billion and $ 17 billion this year. , while its forecasts for 2021 were 16 to 17 billion euros.

(1 $ = 0,8824 euros)

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.